Biological Features of KLC2 Mutations in Chronic Myeloid Leukemia and Their Contribution to Inducing Drug Resistance
Oncology Research · 2026
DOI: 10.32604/or.2025.070259 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Rabindranath Bera und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology-Oncology, Chang Gung Memorial Hospital-Linkou, Taoyuan City, 333, Taiwan. Hauptthemen laut MEDLINE: Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Drug Resistance, Neoplasm, Mutation, Microtubule-Associated Proteins. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology-Oncology, Chang Gung Memorial Hospital-Linkou, Taoyuan City, 333, Taiwan.
- Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, 6068501, Japan.
- Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, 6068501, Japan.
- School of Medicine, Chang Gung University, Taoyuan City, 333, Taiwan.
- Division of Cancer Evolution, National Cancer Center Research Institute, Tokyo, 1040045, Japan.
Zitieren
APA
Bera, R., Ochi, Y., Huang, Y. J., Kuo, M. C., Yoshida, K., Ogawa, S., & Shih, L. Y. (2026). Biological Features of KLC2 Mutations in Chronic Myeloid Leukemia and Their Contribution to Inducing Drug Resistance. Oncology Research. https://doi.org/10.32604/or.2025.070259
Vancouver
Bera R, Ochi Y, Huang YJ, Kuo MC, Yoshida K, Ogawa S, et al. Biological Features of KLC2 Mutations in Chronic Myeloid Leukemia and Their Contribution to Inducing Drug Resistance. Oncology Research. 2026. doi:10.32604/or.2025.070259
BibTeX
@article{Bera2026,
author = {Bera, Rabindranath and Ochi, Yotaro and Huang, Ying-Jung and Kuo, Ming-Chung and Yoshida, Kenichi and Ogawa, Seishi and Shih, Lee-Yung},
title = {Biological Features of KLC2 Mutations in Chronic Myeloid Leukemia and Their Contribution to Inducing Drug Resistance},
journal = {Oncology Research},
year = {2026},
doi = {10.32604/or.2025.070259}
}
EUVIMED